Crossmark

Facilitators and barriers for harm reduction after first use of novel nicotine delivery devices: a qualitative investigation of cigarette smokers

Published Online: 2022-07-29

Authors

Kinchen, Gill http://orcid.org/0000-0001-8156-1413
Cox, Sharon

Kale, Dimitra

Shahab, Lion
License Information

Text and Data Mining valid from 2022-07-29

Version of Record valid from 2022-07-29
More Information

Article History

Received: 28 October 2021

Accepted: 29 June 2022

First Online: 29 July 2022

Declarations

:

: This study has been approved by the UCL Ethics Committee (Project ID Number: 12621/001). Written informed consent to participate was obtained from all participants.

: Authors consent to publication. Written informed consent for publication of personal details was obtained from all participants.

: LS has received a research grant and honoraria for a talk and travel expenses from manufacturers of smoking cessation medications (Pfizer and Johnson & Johnson). None of the authors have ever received personal fees or research funding of any kind from electronic cigarette or tobacco companies. The remaining authors declare that they have no competing interests.

Document is current